Combined effects of arginine and hydroxyurea on BFU-e derived colony growth and HbF synthesis in erythroid progenitors isolated from sickle cell blood

Cellular and Molecular Biology

Volumn 56, Issue SUPPL.1, 2010, Pages

  Baliga, B S ^a   Haynes Jr , J ^a,b   Obiako, B ^a   Mishra, N ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

Author keywords

Cytostatic effect; NG nitro L arginine methyl ester; Nitric oxide cGMP pathway; Proliferative effect

Indexed keywords

ARGININE; HEMOGLOBIN F; HYDROXYUREA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; BLOOD; BURST FORMING UNIT E; CELL ISOLATION; CELL PROLIFERATION; COLONY FORMING UNIT E; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; ERYTHROID PRECURSOR CELL; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; SICKLE CELL; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; BIOSYNTHESIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

ANEMIA, SICKLE CELL; ARGININE; CELL PROLIFERATION; ERYTHROID PRECURSOR CELLS; FETAL HEMOGLOBIN; HUMANS; HYDROXYUREA; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 79952201247     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/148     Document Type: Article

References (24)

1. Azizi E., Dror Y. and Wallis K. Arginase activity in erythrocytes of healthy and ill children. Clinica. Chimica. Acta. 1970, 28: 391-396.
2. Baliga B.S., Pace S.B., Chen Hsueh-Hue, Shah A.K. and Yang Y-M. Mechanism for HbF induction by hydroxyurea in sickle cell erythroid progenitors. Am. J. Hematol. 2000, 65: 227-232.
3. Charache S., Dover G.J., Moore R.D., Eckert S., Ballas S.K., Koshy M., Milner P.F., Orringer E.P., Phillips G., Jr., Platt O.S. and et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992, 79: 2555-2565.
4. Charache S., Terrin M.L., Moore R.D., Dover G.J., Barton F.B., Eckert S.V., McMahon R.P. and Bonds D.R. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N. Engl. J. Med. 1995, 332: 1317-1322.
5. Cokic V.P., Beleslin-Cokic B.B., Tomic M., Stojilkovic S.S., Noguchi C.T., and Schechter A.N. Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells. Blood 2006, 108: 184-191.
6. Cokic V.P., Smith R.D., Beleslin-Cokic B.B., Njoroge J.M., Miller J.L., Gladwin M.T. and Schechter A.N. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J. Clin. Invest. 2003, 111: 231-239.
7. Enwonwu C.O., Xu X. and Turner E. Nitrogen metabolism in sickle cell anemia: Free amino acids in plasma and urine. Am. J. Med. Sci. 1990, 300: 366-71.
8. Enwonwu C.O. Increased metabolic demand for arginine in sickle cell anaemia. Med. Sci. Res. 1989, 17: 997-998.
9. Fibach E., Burke L.P., Schechter A.N., Noguchi C.T. and Rodgers G.P. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia. Blood 1993, 81: 1630-1635.
10. Haynes J., Jr., Baliga B.S., Obiako B., Ofori-Acquah S. and Pace B. Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway. Blood 2004, 103: 3945-3950.
11. Ikuta T., Ausenda S. and Cappellini M.D. Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proc. Natl. Acad. Sci. U. S. A. 2001, 98: 1847-1852.
12. Iyamu E.W., Adunyah S.E., Fasold H., Horiuchi K., Baliga B.S., Ohene-Frempong K., Turner E.A. and Asakura T. Combined use of non-myelosuppressive nitrosourea analogues with hydroxyurea in the induction of F-cell production in human erythroleukemic cell line. Exp. Hematol. 2003, 31: 592-600.
13. Iyamu E.W., Cecil R., Parkin L., Woods G., Ohene-Frempong K. and Asakura T. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy. Br. J. Haematol. 2005, 131: 389-394.
14. Morris C.R., Kato G.J., Poljakovic M., Wang X., Blackwelder W.C., Sachdev V., Hazen S.L., Vichinsky E.P., Morris S.M. Gladwin M.T. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. J.A.M.A. 2005, 294: 81-90.
15. Morris C.R., Kuypers F.A., Larkin S., Vichinsky E.P. and Styles L.A. Patterns of Arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J. Pediatr. Hematol. Oncol. 2000, 22(6):515-520.
16. Morris C.R., Morris S.M., Jr., Hagar W., van Warmerdam J., Claster S., Kepka-Lenhart D., Machado L., Kuypers F.A. and Vichinsky E.P. Arginine Therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am. J. Respir. Crit. Care. Med. 2003, 168: 63-69.
17. Morris C.R., Vichinsky E.P., van Warmerdam J., Machado L., Kepka-Lenhart D., Morris S.M., Jr. and Kuypers F.A. Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J. Pediatr. Hematol. Oncol. 2003, 25: 629-634.
18. Morris S.M., Jr. Recent advances in arginine metabolism: roles and regulation of the arginases. Brit. J. Pharm. doi:10.1111/j.1476-5381.2009.00278.x
19. Rodgers G.P., Dover G.J., Noguchi C.T., Schechter A.N. and Nienhuis A.W. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N. Engl. J. Med. 1990, 322: 1037-1045.
20. Styles L., Kuypers F., Kesler K., Reiss U., Lebeau P., Nagel R. and Fabry M. Arginine therapy does not benefit children with sickle cell anemia - results of the CSCC Clinical Trial Consortium Multi-Institutional Study., edited by Blood. ASH Annual Meeting Abstracts, 2007, p. 2252.
21. Teerlink T., Nijveldt R.J., de Jong, S. and van Leeuwen P.A.M. Determination of arginine, asymmetric dimenthylarginine in human plasma and other biological samples by high-performance liquid chromatography. Analytical Biochemistry 2002, 303: 131-137.
22. Wu G. and Morris S.M., Jr. Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998, 336 ( Pt 1): 1-17.
23. Yang Y.M., Pace B., Kitchens D., Ballas S.K., Shah A. and Baliga B.S. BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction. Am. J. Hematol. 1997, 56: 252-258.
24. Zar J.H., In: Biostatistical Analysis, Prentice-Hall, New Jersey, 1974, p.153